CDSCO panel tells Glenmark to provide in-vivo data, global data concerning Pulmonary FDC in inhalation suspension Roshni Dhar1 Oct 2023 3:15 PM ISTIn reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary drug...
Health Bulletin 30/September/2023 Roshni Dhar30 Sept 2023 4:22 PM ISTHere are the top health stories for the day:Names of medical colleges not paying stipend to medicos should be made publicStating that the names of the...
Provide in-vivo data, global data: CDSCO Panel Tells Glenmark on Pulmonary FDC in Inhalation Suspension Dr. Divya Colin28 Sept 2023 6:00 PM ISTNew Delhi: In reaction to the request for a waiver of bioequivalence (BE) and Phase III clinical trials for the inhalation suspension of the pulmonary...
Lupin Gets CDSCO Panel Nod for Phase IV CT of pulmonary FDC drug Dr. Divya Colin11 April 2023 6:00 PM ISTNew Delhi: Pharmaceutical major, Lupin has got the go ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Amend revised Phase IV CT protocol: CDSCO panel tells GSK on Respiratory Drug Combination Dr. Divya Colin3 Jan 2023 5:45 PM ISTNew Delhi: In response to the GSK's revised Phase IV clinical trial protocol for the pulmonary fixed dose combination (FDC) drug, Fluticasone...
GSK pharma's Mepolizumab to be used on prescription of experienced Registered Medical Specialists: CDSCO Panel Dr. Divya Colin26 Nov 2022 6:00 PM ISTNew Delhi: Approving for the amendment in warning statement for GSK Pharmaceuticals' Mepolizumab 100 mg, the Subject Expert Committee (SEC) functional...
MSN Laboratories gets CDSCO panel nod to manufacture, market Icatibant Injection Dr. Divya Colin18 Nov 2022 6:00 PM ISTNew Delhi: Directing that the drug should be sold by retail under the prescription of the designated medical specialist only, the Subject Expert...
